Skip to main content
. 2019 May 29;9:8025. doi: 10.1038/s41598-019-44485-9

Figure 1.

Figure 1

Study Design and Modulation of Arthritis Score by Ashwashila. (A) Male Balb/c mice of 6–8 weeks’ age were injected intraperitoneally with 1.5 mg/mouse dose of anti-collagen antibody (C-Ab) cocktail and 50 µg/mouse of bacterial lipopolysaccharide (LPS). All the disease and treatment group animals were selected randomly from the C-ab induced arthritis (CAIA) animals. The normal (NC) and disease control (DC) animals were treated with sodium carboxymethyl cellulose (Na-CMC) while the treatment group CAIA mice were treated with 353 mg/kg oral dose of ASHW and 0.38 mg/kg oral dose of MTX given every alternate day for two weeks. Physical and clinical parameters of the animals were measured every day throughout the experimental duration. (B) Arthritis score showed an increase in the CAIA animals indicating the onset of RA. Treatment of the CAIA mice with ASHW and MTX significantly reduced the arthritis score indicating a reduction in pedal swellings. (C) Anti-arthritic activity analysis based on the arthritis score showed similar efficacy for both ASHW and MTX except on day 16. Results represent Mean ± SEM. A one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparison t-test was used to calculate the statistical difference. Student unpaired t-test was used to calculate the statistical difference in comparison to MTX (p-value * ≤ 0.05; ** ≤ 0.01).